Want to see PCSA full AI Analyst Report?
Processa Pharmaceuticals (PCSA) Q2 2024 Earnings Report
PCSA Q2 2024 EPS Results
- Actual EPS
- -$25.25
- Consensus EPS
- -$25.25
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -$50.00
PCSA Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/28/2024
- Time
- Before Open
- Conference Call
- Wednesday, August 28, 2024
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
PCSA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 06, 2026 | 2026 (Q2) | ―-1.19 | -6.25 | 81.01% (+5.06) | |
| Nov 05, 2025 | 2025 (Q3) | -2.00-1.81 | -25.75 | 92.98% (+23.94) | |
| Aug 07, 2025 | 2025 (Q2) | -0.22-0.25 | -1.01 | 75.25% (+0.76) | |
| Mar 27, 2025 | 2024 (Q4) | -0.84-0.77 | -1.7 | 54.71% (+0.93) | |
| Oct 30, 2024 | 2024 (Q3) | -25.00-25.75 | -40 | 35.63% (+14.25) | |
| Aug 28, 2024 | 2024 (Q2) | -25.25-25.25 | -50 | 49.50% (+24.75) | |
| Mar 28, 2024 | 2023 (Q4) | -1.60-1.65 | -16.2 | 89.81% (+14.55) | |
| Nov 08, 2023 | 2023 (Q3) | -0.10-0.08 | -0.37 | 78.38% (+0.29) | |
| Aug 10, 2023 | 2023 (Q2) | -0.15-0.10 | -0.32 | 68.75% (+0.22) | |
| May 11, 2023 | 2023 (Q1) | -0.28-0.18 | -0.2 | 10.00% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
